BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 942141)

  • 1. Letter: Regression of focal nodular hyperplasia after discontinuation of oral contraceptives.
    Ross D; Pina J; Mirza M; Galvan A; Ponce L
    Ann Intern Med; 1976 Aug; 85(2):203-4. PubMed ID: 942141
    [No Abstract]   [Full Text] [Related]  

  • 2. Hepatic adenomas and focal nodular hyperplasia of the liver in young women on oral contraceptives: case reports.
    Jhingran SG; Mukhopadhyay AK; Ajmani SK; Johnson PC
    J Nucl Med; 1977 Mar; 18(3):263-6. PubMed ID: 839274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Oral contraceptives and benign tumorous conditions of the liver (author's transl)].
    Lesch R; Hoppe-Seyler P; Heissmeyer HH; Hoensch D; Jenss H; Wimmer B; Wenz W
    Radiologe; 1980 Dec; 20(12):565-76. PubMed ID: 7208890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Focal nodular hyperplasia of great extent in the liver after taking oral contraceptives].
    Szécsény A; Faller J; Lapis K; Schaff Z
    Orv Hetil; 1984 Mar; 125(12):687-91. PubMed ID: 6709335
    [No Abstract]   [Full Text] [Related]  

  • 5. Benign hepatic tumors secondary to oral contraceptives.
    Malt S; Shieber W
    Mo Med; 1976 Oct; 73(10):561-4. PubMed ID: 1012256
    [No Abstract]   [Full Text] [Related]  

  • 6. Focal nodular hyperplasia of the liver and oral contraceptives.
    Kinch R; Lough J
    Am J Obstet Gynecol; 1978 Dec; 132(7):717-27. PubMed ID: 213973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral contraceptive-induced hepatic adenoma and focal nodular hyperplasia.
    Bryant CJ; Hoy RJ
    Australas Radiol; 1980 Nov; 24(3):289-92. PubMed ID: 7236169
    [No Abstract]   [Full Text] [Related]  

  • 8. Oral contraceptives, pregnancy, and focal nodular hyperplasia of the liver.
    Scott LD; Katz AR; Duke JH; Cowan DF; Maklad NF
    JAMA; 1984 Mar; 251(11):1461-3. PubMed ID: 6700042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liver tumors and oral contraceptives.
    Ansari AH; Ravry MJ; Stanton PE; Hanafi M
    Fertil Steril; 1978 Jun; 29(6):643-50. PubMed ID: 658476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Benign hepatic lesions and orally administered contraceptives. A report of seven cases and a critical analysis of the literature.
    Fechner RE
    Hum Pathol; 1977 May; 8(3):255-68. PubMed ID: 192659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sex hormones and hepatic neoplasia.
    Goldfarb S
    Cancer Res; 1976 Jul; 36(7 PT 2):2584-8. PubMed ID: 179705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progressive enlargement of an hepatic cell adenoma.
    Mariani AF; Livingstone AS; Pereiras RV; van Zuiden PE; Schiff ER
    Gastroenterology; 1979 Dec; 77(6):1319-25. PubMed ID: 499719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatic adenoma and focal nodular hyperplasia.
    Shortell CK; Schwartz SI
    Surg Gynecol Obstet; 1991 Nov; 173(5):426-31. PubMed ID: 1658955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Oral hormonal contraceptives and benign liver tumors].
    Giedl J; Gebhardt C
    Fortschr Med; 1981 Feb; 99(6):165-70. PubMed ID: 7274960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumorigenic aspects.
    Kirk ME
    Int J Gynaecol Obstet; 1978-1979; 16(6):473-8. PubMed ID: 39811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Adenoma of the liver and focal nodular hyperplasia. Relationship with oral contraceptives (author's transl)].
    Goldfarb G; Benhamou JP
    Gastroenterol Clin Biol; 1979 May; 3(5):465-72. PubMed ID: 395012
    [No Abstract]   [Full Text] [Related]  

  • 17. Benign liver tumors and oral contraceptives.
    Aungst CW
    N Y State J Med; 1978 Oct; 78(12):1933-4. PubMed ID: 212701
    [No Abstract]   [Full Text] [Related]  

  • 18. Proper management of hepatic adenoma associated with oral contraceptives.
    Chan CK; Detmer DE
    Surg Gynecol Obstet; 1977 May; 144(5):703-6. PubMed ID: 66762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral contraceptive steroids as promoters of hepatocarcinogenesis in female Sprague-Dawley rats.
    Yager JD; Yager R
    Cancer Res; 1980 Oct; 40(10):3680-5. PubMed ID: 6108158
    [No Abstract]   [Full Text] [Related]  

  • 20. Benign hepatic lesions in women taking oral contraceptives.
    Davis TJ; Berk RN
    Gastrointest Radiol; 1977 Dec; 2(3):213-9. PubMed ID: 210082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.